United States · FDA National Drug Code directory
NITROFURANTOIN (monohydrate/macrocrystals)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42708-184_4586f98c-081a-3d32-e063-6394a90aeb5a
- Product NDC
- 42708-184
- Form
- CAPSULE
- Composition / generic term
- Nitrofurantoin (monohydrate/macrocrystals)
- Labeler
- QPharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220222
- Source listing expiry
- 20261231
Source-listed ingredients
- NITROFURANTOIN MONOHYDRATE — 75 mg/1
- NITROFURANTOIN — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 CAPSULE in 1 BOTTLE, PLASTIC (42708-184-14) · 42708-184-14
- 28 CAPSULE in 1 BOTTLE, PLASTIC (42708-184-28) · 42708-184-28
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →